Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Role of ALK Inhibitors in Anap...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Role of ALK Inhibitors in Anaplastic Large Cell Lymphoma—Experience from an Indian Center

Role of ALK Inhibitors in Anaplastic Large Cell Lymphoma—Experience from an Indian Center

Bibliographic Details
Main Authors: Muthiah Vaikundaraja Indhuja, Sivasree Kesana, Nikita Mehra, Parathan Karunakaran, Arun Kumar Rajan, Venkatraman Radhakrishnan, Perumal Kalaiyarasi Jayachandran
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2024-04-01
Series:South Asian Journal of Cancer
Subjects:
ALK+ ALCL
anaplastic large cell lymphoma
crizotinib in ALCL
ALK inhibitors in ALCL
relapsed refractory ALCL
targeted therapy in NHL
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1758353
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1758353

Similar Items

  • ALK + anaplastic large cell lymphoma involving the bladder: case report and review of the literature
    by: Ying Zhao, et al.
    Published: (2024-12-01)
  • ALK inhibitors, a pharmaceutical perspective
    by: Arturo eGalvani, et al.
    Published: (2012-02-01)
  • Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma
    by: Yuan Wang, et al.
    Published: (2022-02-01)
  • Anaplastic large cell lymphoma with ALK::ATIC fusion mimicking a histiocytic sarcoma debuting as an anterior thoracic soft tissue tumor with exceptional clinicopathological, morphological and molecular features
    by: José Antonio García‐Muñiz, et al.
    Published: (2024-05-01)
  • Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK‐positive anaplastic large‐cell lymphoma refractory to chemotherapy and brentuximab vedotin
    by: Ritsuko Nakai, et al.
    Published: (2019-12-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs